Cardiorespiratory Fitness and Cardiac Magnetic Resonance Imaging in Childhood Acute Lymphoblastic Leukemia Survivors

J Phys Act Health. 2023 Mar 27;20(6):522-530. doi: 10.1123/jpah.2022-0179. Print 2023 Jun 1.

Abstract

Background: Childhood acute lymphoblastic leukemia survivors' anthracycline-induced cardiotoxicity could be prevented with good cardiorespiratory fitness levels and regular physical activity. This cross-sectional study aimed to assess the association between cardiorespiratory fitness and physical activity with cardiac magnetic resonance parameters.

Methods: A total of 96 childhood acute lymphoblastic leukemia survivors underwent a maximal cardiopulmonary exercise test and answered physical activity questionnaires. We calculated the odds ratio of the preventive fraction of regular physical activity (≥150 min/wk) and adequate cardiorespiratory fitness levels (above the median ≥31.4 mL·kg-1·min-1) on cardiac magnetic resonance parameters (left ventricular [LV] and right ventricular [RV] morphological and functional parameters).

Results: An adequate cardiorespiratory fitness was associated with a significant preventive fraction for LV (up to 84% for LV end-diastolic volume) and RV volumes (up to 88% for RV end-systolic volume). The adjusted analyses highlighted a preventive fraction of 36% to 91% between an adequate cardiorespiratory fitness and LV and RV parameters, late gadolinium enhancement fibrosis, and cardiac magnetic resonance relaxation times. No associations were reported with regular physical activity.

Conclusions: This study provides additional evidence regarding the benefits of an adequate cardiorespiratory fitness level for childhood cancer survivors' cardiac health.

Keywords: cardiac function; preventive fraction; survivorship.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiorespiratory Fitness*
  • Contrast Media
  • Cross-Sectional Studies
  • Exercise
  • Gadolinium
  • Humans
  • Magnetic Resonance Imaging
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Survivors

Substances

  • Contrast Media
  • Gadolinium

Grants and funding